scispace - formally typeset
J

Jeroen Wagemans

Researcher at Katholieke Universiteit Leuven

Publications -  65
Citations -  1111

Jeroen Wagemans is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 11, co-authored 39 publications receiving 457 citations.

Papers
More filters
Journal ArticleDOI

Global phylogeography and ancient evolution of the widespread human gut virus crAssphage

Robert Edwards, +120 more
- 08 Jul 2019 - 
TL;DR: It is concluded that crAssphage is a benign cosmopolitan virus that may have coevolved with the human lineage and is an integral part of the normal human gut virome.
Journal ArticleDOI

Bacteriophage Application for Difficult-to-treat Musculoskeletal Infections: Development of a Standardized Multidisciplinary Treatment Protocol.

TL;DR: The first steps towards the establishment of a “multidisciplinary phage task force” (MPTF) and a standardized treatment pathway for patients with severe musculoskeletal infection are presented.
Posted ContentDOI

Global phylogeography and ancient evolution of the widespread human gut virus crAssphage

Robert Edwards, +118 more
- 26 Jan 2019 - 
TL;DR: It is concluded that crAssphage is a benign globetrotter virus that may have co-evolved with the human lineage and an integral part of the normal human gut virome.
Journal ArticleDOI

A Multifaceted Study of Pseudomonas aeruginosa Shutdown by Virulent Podovirus LUZ19

TL;DR: A multifaceted study combining quantitative PCR, microarray, RNA-seq, and two-dimensional gel electrophoresis to obtain a global overview of alterations in DNA, RNA, and protein content in Pseudomonas aeruginosa PAO1 cells upon infection with the strictly lytic phage LUZ19 finds new features of phage infection.
Journal ArticleDOI

Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae

TL;DR: A 30-year-old bombing victim with a fracture-related pandrug-resistant Klebsiella pneumoniae infection after long-term (>700 days) antibiotic therapy is treated with a pre-adapted bacteriophage along with meropenem and colistin, followed by ceftazidime/avibactam as mentioned in this paper .